EA201200710A1 - Drug, possessing anti-virus, anti-bacterial, anti-fungal, anti-inflammatory, and method of its production - Google Patents

Drug, possessing anti-virus, anti-bacterial, anti-fungal, anti-inflammatory, and method of its production

Info

Publication number
EA201200710A1
EA201200710A1 EA201200710A EA201200710A EA201200710A1 EA 201200710 A1 EA201200710 A1 EA 201200710A1 EA 201200710 A EA201200710 A EA 201200710A EA 201200710 A EA201200710 A EA 201200710A EA 201200710 A1 EA201200710 A1 EA 201200710A1
Authority
EA
Eurasian Patent Office
Prior art keywords
levorin
drug
citral
dimethyl sulfoxide
action
Prior art date
Application number
EA201200710A
Other languages
Russian (ru)
Other versions
EA022317B1 (en
Inventor
Вафа Халил Кызы Ибрагимова
Халил Мамедали оглы Касумов
Original Assignee
Халил Мамедали оглы Касумов
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Халил Мамедали оглы Касумов filed Critical Халил Мамедали оглы Касумов
Priority to EA201200710A priority Critical patent/EA022317B1/en
Publication of EA201200710A1 publication Critical patent/EA201200710A1/en
Publication of EA022317B1 publication Critical patent/EA022317B1/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Изобретение относится к медицине и фармакологии, а именно к содержащим антибиотик леворин лекарственным средствам, обладающим химиотерапевтической активностью против возбудителей вирусных, стафилококковых и грибковых инфекций, а также к веществам, обладающим противоожоговыми свойствами, как in vitro, так и in vivo, косметическим и гигиеническим действием. Поставленная задача достигается тем, что лекарственное средство, обладающее антивирусным, антибактериальным, антигрибковым, противоожоговым действием на основе леворина, содержащего диметилсульфоксид, согласно изобретению, дополнительно включает цитраль, а в качестве леворина содержит леворин Aпри следующем соотношениии компонентов, мас.%: леворин А- 0,001-5; цитраль - 0,1-50; диметилсульфоксид - остальное. Задачей изобретения также является создание способа получения лекарственного средства, обладающего антивирусным, антибактериальным, антигрибковым, противоожоговым, косметическим и гигиеническим действием. Поставленная задача достигается тем, что в качестве леворина берут леворин A, который растворяют в цитрале с последующим добавлением раствора диметилсульфоксида и дополнительно вводят в смесь по меньшей мере еще один компонент, такой как фармацевтически приемлемое активное вещество и/или ароматизатор, и/или краситель, и/или загуститель при следующем соотношении, мас.%: лекарственное средство - 5,0-50, дополнительно фармацевтически приемлемые компоненты - остальное.The invention relates to medicine and pharmacology, namely to drugs containing antibiotic levorin, having chemotherapeutic activity against pathogens of viral, staphylococcal and fungal infections, as well as to substances having anti-burn properties, both in vitro and in vivo, cosmetic and hygienic action . The task is achieved by the fact that the drug has antiviral, antibacterial, antifungal, anti-burn action on the basis of levorin containing dimethyl sulfoxide, according to the invention, additionally includes citral, and as levorin contains levorin A with the following ratio of components, wt.%: Levorin A- 0.001-5; citral - 0.1-50; dimethyl sulfoxide - the rest. The invention is also the creation of a method of obtaining drugs with antiviral, antibacterial, antifungal, antiburn, cosmetic and hygienic action. The task is achieved by taking levorin A as levorin, which is dissolved in citral followed by the addition of a solution of dimethyl sulfoxide and additionally inject at least one more component into the mixture, such as pharmaceutically acceptable active substance and / or flavoring, and / or dye, and / or thickener in the following ratio, wt.%: drug - 5.0-50, additionally pharmaceutically acceptable components - the rest.

EA201200710A 2011-07-01 2011-07-01 Medication possessing antiviral, antibacterial, antifungal, burn-treating action and method for obtaining the same EA022317B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EA201200710A EA022317B1 (en) 2011-07-01 2011-07-01 Medication possessing antiviral, antibacterial, antifungal, burn-treating action and method for obtaining the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EA201200710A EA022317B1 (en) 2011-07-01 2011-07-01 Medication possessing antiviral, antibacterial, antifungal, burn-treating action and method for obtaining the same

Publications (2)

Publication Number Publication Date
EA201200710A1 true EA201200710A1 (en) 2013-01-30
EA022317B1 EA022317B1 (en) 2015-12-30

Family

ID=47604437

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201200710A EA022317B1 (en) 2011-07-01 2011-07-01 Medication possessing antiviral, antibacterial, antifungal, burn-treating action and method for obtaining the same

Country Status (1)

Country Link
EA (1) EA022317B1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2053768C1 (en) * 1993-12-16 1996-02-10 Товарищество с ограниченной ответственностью "Элест" Method of preparing water-soluble polyene antibiotics
US7905852B2 (en) * 2006-05-16 2011-03-15 Barbara Jennings-Spring Skin-contacting-adhesive free dressing
US7465700B1 (en) * 2007-06-20 2008-12-16 The Clorox Company Natural cleaning compositions

Also Published As

Publication number Publication date
EA022317B1 (en) 2015-12-30

Similar Documents

Publication Publication Date Title
EA201591027A1 (en) POLYCYCLIC CARBAMOILPYRIDONE COMPOUNDS AND THEIR PHARMACEUTICAL APPLICATIONS
CY1119544T1 (en) POLYCyclic Carbamoyl Pyridone Compounds and Their Use in the Treatment of HIV Infection
EA201791019A1 (en) POLYCYCLIC CARBAMOILPYRIDONE COMPOUNDS AND THEIR PHARMACEUTICAL APPLICATIONS
HRP20180007T1 (en) Formulation comprising a gemcitabine-prodrug
CO2017011411A2 (en) Derivatives of amido substituted cyclohexane
EA201891103A1 (en) COMPOSITIONS FOR THE TREATMENT OF SPINAL MUSCULAR ATROPHY
NZ735575A (en) Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
AR098576A1 (en) PHARMACEUTICAL PRODUCT
EA201790389A1 (en) PYRROPYRIMIDINE COMPOUNDS USED AS AN AGLIST TLR7
CO6460769A2 (en) NEW VIRAL REPLICATION INHIBITORS
WO2013123215A3 (en) Antiviral drugs for treatment of arenavirus infection
EA201070597A1 (en) ANTIBACTERIAL ANALOGUES OF AMINOGLICOSIDE
EA202090762A1 (en) INJECTED DELAYED RELEASE PREPARATIONS CONTAINING ISOXAZOLINE ACTIVE SUBSTANCE, METHODS AND APPLICATIONS
EA201690183A1 (en) SUBSTITUTED PYRAZOLOPIRIDINAMINES
EA201591618A1 (en) SUBSTITUTED IMIDAZOPIRIDAZINES
EA201691490A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING BRINZOLAMIDE
UY35848A (en) TIENOPIRIMIDINS
CY1119542T1 (en) MICRONISM PRODUCT CONTAINING ACUTE ULIPRISTAL
EA201500710A1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF HIV INFECTIONS
UA109544C2 (en) PHARMACEUTICAL COMPOSITION CONTAINING PARACETAMOL AND METHOD OF MANUFACTURING
EA201200710A1 (en) Drug, possessing anti-virus, anti-bacterial, anti-fungal, anti-inflammatory, and method of its production
EA201992544A1 (en) ISOTRETINOIN PEPTIDE CONJUGATE
EA201590415A1 (en) DERIVATIVES OF DIAZEPINONA APPLICABLE FOR THE TREATMENT OF SYNDROME WITH Fragile X-CHROMOSOME, PARKINSON'S DISEASE OR REFLUX DISEASE
RU2016101248A (en) LYOPHILIZED PRODUCTS BENDAMUSTINE HYDROCHLORIDE
UA97076C2 (en) Anti-inflammatory ointment based on sulfanilamide

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM BY KZ KG MD TJ TM RU

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AZ

NF4A Restoration of lapsed right to a eurasian patent

Designated state(s): AZ

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AZ